BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 26150616)

  • 1. A case of neurosarcoidosis secondary to treatment of etanercept and review of the literature.
    Berrios I; Jun-O'Connell A; Ghiran S; Ionete C
    BMJ Case Rep; 2015 Jul; 2015():. PubMed ID: 26150616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes of refractory neurosarcoidosis treated with infliximab.
    Cohen Aubart F; Bouvry D; Galanaud D; Dehais C; Mathey G; Psimaras D; Haroche J; Pottier C; Hie M; Mathian A; Devilliers H; Nunes H; Valeyre D; Amoura Z
    J Neurol; 2017 May; 264(5):891-897. PubMed ID: 28260120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations: similarities and differences.
    Favalli EG; Pontikaki I; Becciolini A; Biggioggero M; Ughi N; Romano M; Crotti C; Gattinara M; Gerloni V; Marchesoni A; Meroni PL
    Clin Rheumatol; 2017 Aug; 36(8):1747-1755. PubMed ID: 28597133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of anti-tumor necrosis factor alpha agents on the outcome in pediatric uveitis of diverse etiologies.
    Deitch I; Amer R; Tomkins-Netzer O; Habot-Wilner Z; Friling R; Neumann R; Kramer M
    Graefes Arch Clin Exp Ophthalmol; 2018 Apr; 256(4):801-808. PubMed ID: 29455252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders.
    Levy-Clarke G; Jabs DA; Read RW; Rosenbaum JT; Vitale A; Van Gelder RN
    Ophthalmology; 2014 Mar; 121(3):785-96.e3. PubMed ID: 24359625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients.
    Riancho-Zarrabeitia L; Calvo-Río V; Blanco R; Mesquida M; Adan AM; Herreras JM; Aparicio Á; Peiteado-Lopez D; Cordero-Coma M; García Serrano JL; Ortego-Centeno N; Maíz O; Blanco A; Sánchez-Bursón J; González-Suárez S; Fonollosa A; Santos-Gómez M; González-Vela C; Loricera J; Pina T; González-Gay MA
    Semin Arthritis Rheum; 2015 Dec; 45(3):361-8. PubMed ID: 26092330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis.
    Saurenmann RK; Levin AV; Rose JB; Parker S; Rabinovitch T; Tyrrell PN; Feldman BM; Laxer RM; Schneider R; Silverman ED
    Rheumatology (Oxford); 2006 Aug; 45(8):982-9. PubMed ID: 16461435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-TNFα agents and methotrexate in spondyloarthritis related uveitis in a Chinese population.
    Lian F; Zhou J; Wei C; Wang Y; Xu H; Liang L; Yang X
    Clin Rheumatol; 2015 Nov; 34(11):1913-20. PubMed ID: 26070537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Effectiveness of Tumor Necrosis Factor Agents and Disease-modifying Antirheumatic Therapy in Children with Enthesitis-related Arthritis: The First Year after Diagnosis.
    Weiss PF; Xiao R; Brandon TG; Pagnini I; Wright TB; Beukelman T; Morgan-DeWitt E; Feudtner C
    J Rheumatol; 2018 Jan; 45(1):107-114. PubMed ID: 28916542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness of tumour necrosis factor-alpha inhibitors as first-line agents in rheumatoid arthritis.
    Spalding JR; Hay J
    Pharmacoeconomics; 2006; 24(12):1221-32. PubMed ID: 17129076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longterm Safety and Efficacy of Adalimumab and Infliximab for Uveitis Associated with Juvenile Idiopathic Arthritis.
    Cecchin V; Zannin ME; Ferrari D; Pontikaki I; Miserocchi E; Paroli MP; Bracaglia C; Marafon DP; Pastore S; Parentin F; Simonini G; De Libero C; Falcini F; Petaccia A; Filocamo G; De Marco R; La Torre F; Guerriero S; Martino S; Comacchio F; Muratore V; Martini G; Vittadello F; Zulian F
    J Rheumatol; 2018 Aug; 45(8):1167-1172. PubMed ID: 29657140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etanercept may induce neurosarcoidosis in a patient treated for rheumatoid arthritis.
    Durel CA; Feurer E; Pialat JB; Berthoux E; Chapurlat RD; Confavreux CB
    BMC Neurol; 2013 Dec; 13():212. PubMed ID: 24373564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermatomyositis induced by anti-tumor necrosis factor in a patient with juvenile idiopathic arthritis.
    Liu SW; Velez NF; Lam C; Femia A; Granter SR; Townsend HB; Vleugels RA
    JAMA Dermatol; 2013 Oct; 149(10):1204-8. PubMed ID: 23986394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-TNF-α therapy in the management of severe neurosarcoidosis: a report of five cases from a single centre and literature review.
    Riancho-Zarrabeitia L; Delgado-Alvarado M; Riancho J; Oterino A; Sedano MJ; Rueda-Gotor J; Pérez-Martín I; González-Vela MC; Berciano J; González-Gay MA; Blanco R
    Clin Exp Rheumatol; 2014; 32(2):275-84. PubMed ID: 24321604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medically refractory neurosarcoidosis treated with infliximab.
    Pereira J; Anderson NE; McAuley D; Bergin P; Kilfoyle D; Fink J
    Intern Med J; 2011 Apr; 41(4):354-7. PubMed ID: 21507165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiological remission and recovery of thirst appreciation after infliximab therapy in adipsic diabetes insipidus secondary to neurosarcoidosis.
    O'Reilly MW; Sexton DJ; Dennedy MC; Counihan TJ; Finucane FM; O'Brien T; O'Regan AW
    QJM; 2015 Aug; 108(8):657-9. PubMed ID: 23417911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor necrosis factor-α therapy in uveitis.
    Cordero-Coma M; Sobrin L
    Surv Ophthalmol; 2015; 60(6):575-89. PubMed ID: 26164735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate for resistant chronic uveitis in children with juvenile rheumatoid arthritis.
    Weiss AH; Wallace CA; Sherry DD
    J Pediatr; 1998 Aug; 133(2):266-8. PubMed ID: 9709718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurosarcoidosis in a patient treated with tumor necrosis factor alpha inhibitors.
    Mao-Draayer Y; Cash T
    J Neurol; 2013 Feb; 260(2):651-3. PubMed ID: 23306600
    [No Abstract]   [Full Text] [Related]  

  • 20. Herpes Virus Infections During Treatment With Etanercept in Juvenile Idiopathic Arthritis.
    Nicolai R; Cortis E; Ravà L; Bracaglia C; Pardeo M; Insalaco A; Buonuomo PS; Tozzi AE; De Benedetti F
    J Pediatric Infect Dis Soc; 2016 Mar; 5(1):76-9. PubMed ID: 26908493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.